# Max India (NSE: MAXIND) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/MAXIND · Pivot · prices to 21 Oct 2026

Max India (NSE: MAXIND) closed at ₹152.59 on 21 Oct 2026. With a market capitalisation of ₹884 Cr, it ranks 1532nd by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Financials sector; its industry is Medical Care Facilities.

Its return on equity was −29.8% in FY26. Over the past year the share price has fallen 26.2%. Its 52-week range is ₹120.00 (30 Mar 2026) to ₹220.99 (21 Oct 2025); the last close is 31.0% below the high. In Q3 FY20, the quarter ended 31 Dec 2019, revenue was ₹34 Cr (−9.7% year on year) and net profit ₹347 Cr, on a consolidated basis. Promoters held 48.33% of the company as of 4 Aug 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Last close | ₹152.59 |
| Market cap | ₹884 Cr |
| ROE | −29.8% (FY26) |
| ROCE | −21.3% (FY26) |
| Debt to equity | 0 |
| 52-week high | ₹220.99 (21 Oct 2025) |
| 52-week low | ₹120.00 (30 Mar 2026) |
| 1-year return | −26.2% |

## Quarterly results (₹ crore, consolidated)

| Quarter | Revenue | Revenue YoY | Net profit | Net profit YoY | EPS (₹) |
| --- | --- | --- | --- | --- | --- |
| Q3 FY20 | ₹34 Cr | −9.7% | ₹347 Cr | — | ₹14.11 |
| Q2 FY20 | ₹39 Cr | +8.7% | −₹28 Cr | — | −₹0.29 |
| Q1 FY20 | ₹38 Cr | −12.3% | −₹99 Cr | — | −₹1.87 |
| Q4 FY19 | ₹40 Cr | — | −₹8 Cr | — | −₹0.43 |
| Q3 FY19 | ₹38 Cr | — | −₹32 Cr | — | — |
| Q2 FY19 | ₹36 Cr | — | −₹71 Cr | — | −₹1.51 |
| Q1 FY19 | ₹43 Cr | — | −₹20 Cr | — | −₹0.70 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹145 Cr | −₹141 Cr |
| FY24 | ₹176 Cr | −₹57 Cr |
| FY23 | ₹201 Cr | −₹9 Cr |
| FY22 | ₹230 Cr | −₹16 Cr |
| FY21 | ₹121 Cr | −₹52 Cr |

## Shareholding (4 Aug 2026)

- Promoters: 48.33%
- Foreign institutions: 6.81%
- Domestic institutions: 5.96%
- Non-institutions: 38.90%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Centrum Capital](https://app.pivotnow.in/stock/CENTRUM) | ₹18.96 | ₹923 Cr | — | — |
| [Wealth First Portfolio Managers](https://app.pivotnow.in/stock/WEALTH) | ₹854.00 | ₹910 Cr | 23.6 | — |
| [Health X Platform](https://app.pivotnow.in/stock/HEALTHX) | ₹278.75 | ₹887 Cr | — | — |
| [Hexa Tradex](https://app.pivotnow.in/stock/HEXATRADEX) | ₹156.39 | ₹864 Cr | — | — |
| [Sobhagya Mercan](https://app.pivotnow.in/stock/SOBME) | — | ₹864 Cr | — | — |
| [IIRM Holdings](https://app.pivotnow.in/stock/IIRM) | — | ₹856 Cr | — | — |

## Questions and answers

### What is the share price of Max India today?

Max India (NSE: MAXIND) last closed at ₹152.59 on 21 Oct 2026. Its 52-week high is ₹220.99 and its 52-week low is ₹120.00.

### What is the market cap of Max India?

Max India's market capitalisation is ₹884 Cr (₹884 Cr) at the 19 Oct 2026 close, ranking 1532nd among the NSE companies Pivot tracks.

### What is the ROE and ROCE of Max India?

Return on equity was −29.8% in FY26 and return on capital employed was −21.3% in FY26 (consolidated figures).

### What were Max India's latest quarterly results?

For Q3 FY20 (quarter ended 31 Dec 2019), Max India reported revenue of ₹34 Cr, −9.7% year on year, and net profit of ₹347 Cr.

### How has Max India stock performed over the last year?

Max India's share price has fallen 26.2% over the past year, −3.3% over three months and +11.1% over one month, to the 19 Oct 2026 close.

### What is the shareholding pattern of Max India?

As of 4 Aug 2026: promoters 48.33%, foreign institutions 6.81%, domestic institutions 5.96%, non-institutions 38.90%.

### Who are Max India's competitors?

The listed Financials companies closest to Max India by market cap are Centrum Capital, Wealth First Portfolio Managers, Health X Platform, Hexa Tradex, Sobhagya Mercan and IIRM Holdings.

### Is Max India a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Max India's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on MAXIND against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.